Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if giving isosorbide,a drug that is used to treat
chest pain, affects blood vessel release of an anti-clotting factor.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center
Collaborators:
National Center for Research Resources (NCRR) National Heart, Lung, and Blood Institute (NHLBI) National Institutes of Health (NIH)